Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

Source: [CNBC](https://www.cnbc.com/2026/08/04/pfizer-pfe-earnings-q2-2026.html)